Autus Asset Management LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 16.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 15,663 shares of the healthcare conglomerate’s stock after selling 2,995 shares during the quarter. Autus Asset Management LLC’s holdings in UnitedHealth Group were worth $7,988,000 as of its most recent SEC filing.
A number of other institutional investors have also modified their holdings of the stock. Wealthcare Capital Management LLC raised its stake in UnitedHealth Group by 42.0% during the 1st quarter. Wealthcare Capital Management LLC now owns 852 shares of the healthcare conglomerate’s stock worth $434,000 after buying an additional 252 shares during the period. Blue Fin Capital Inc. raised its stake in UnitedHealth Group by 0.9% during the 1st quarter. Blue Fin Capital Inc. now owns 14,006 shares of the healthcare conglomerate’s stock worth $7,142,000 after buying an additional 119 shares during the period. Griffin Asset Management Inc. raised its stake in UnitedHealth Group by 0.3% during the 1st quarter. Griffin Asset Management Inc. now owns 6,695 shares of the healthcare conglomerate’s stock worth $3,414,000 after buying an additional 21 shares during the period. Stonnington Group LLC raised its stake in UnitedHealth Group by 7.8% during the 1st quarter. Stonnington Group LLC now owns 27,583 shares of the healthcare conglomerate’s stock worth $14,824,000 after buying an additional 1,985 shares during the period. Finally, MCIA Inc raised its stake in UnitedHealth Group by 1.3% during the 1st quarter. MCIA Inc now owns 3,786 shares of the healthcare conglomerate’s stock worth $2,035,000 after buying an additional 50 shares during the period. 87.48% of the stock is currently owned by institutional investors and hedge funds.
NYSE UNH opened at $489.68 on Thursday. The firm’s fifty day moving average price is $496.56 and its two-hundred day moving average price is $490.86. The stock has a market cap of $459.40 billion, a PE ratio of 26.80, a PEG ratio of 1.41 and a beta of 0.83. UnitedHealth Group Incorporated has a fifty-two week low of $383.12 and a fifty-two week high of $553.29. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.78 and a current ratio of 0.78.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 28th. Investors of record on Monday, June 20th will be paid a $1.65 dividend. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.45. The ex-dividend date is Thursday, June 16th. This represents a $6.60 annualized dividend and a dividend yield of 1.35%. UnitedHealth Group’s payout ratio is currently 36.12%.
Several analysts have issued reports on UNH shares. Raymond James lifted their price target on UnitedHealth Group from $540.00 to $620.00 and gave the company a “strong-buy” rating in a research note on Tuesday, April 19th. Loop Capital started coverage on UnitedHealth Group in a research note on Thursday, June 16th. They issued a “buy” rating and a $575.00 price target on the stock. Credit Suisse Group lifted their price target on UnitedHealth Group from $564.00 to $595.00 and gave the company an “outperform” rating in a research note on Monday, April 18th. Morgan Stanley lifted their price target on UnitedHealth Group from $570.00 to $577.00 and gave the company an “overweight” rating in a research note on Monday, April 18th. Finally, SVB Leerink raised their price objective on UnitedHealth Group from $550.00 to $600.00 and gave the company an “outperform” rating in a report on Tuesday, April 19th. Three equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $555.73.
In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of the company’s stock in a transaction on Thursday, May 19th. The shares were sold at an average price of $478.96, for a total transaction of $1,197,400.00. Following the sale, the director now owns 1,215,000 shares of the company’s stock, valued at $581,936,400. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Frederick William Mcnabb III purchased 89 shares of the business’s stock in a transaction on Thursday, May 26th. The shares were purchased at an average cost of $504.32 per share, for a total transaction of $44,884.48. Following the transaction, the director now directly owns 11,259 shares of the company’s stock, valued at approximately $5,678,138.88. The disclosure for this purchase can be found here. Insiders own 0.40% of the company’s stock.
UnitedHealth Group Profile (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- Downturn Gives These 3 Buys Juicy Dividend Yields
- Victoria’s Secret Stock is Out of the Box
- Time For a Ride in Six Flags Stock
- Why Dollar General (NYSE: DG) Should Be In Your Portfolio
- Korn Ferry Is A Good Buy For The Recession And Beyond
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.